Predicate |
Object |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-71 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-91205 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-52 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57415 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68 |
filingDate |
2011-01-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate |
2013-05-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
JP-2013517461-A |
titleOfInvention |
A method for predicting triple-negative breast cancer response to therapy |
abstract |
The present invention provides compositions and methods for detecting expression and / or activation levels of components of signal transduction pathways in tumor cells, such as triple negative metastatic breast tumor cells. Information regarding the expression and / or activation levels of signal transduction pathway components obtained by use of the present invention can be used in cancer diagnosis, prognosis and cancer treatment planning. [Selection] FIG. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2017065277-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-WO2017065277-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10724071-B2 |
priorityDate |
2010-01-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |